Cargando…
How persons with systemic mastocytosis describe the time between symptom onset and receiving diagnosis
AIM: The aim of the study was to explore how persons with systemic mastocytosis (SM) described the time between the onset of symptoms and signs and getting the diagnosis. BACKGROUND: SM is a rare disease caused by the accumulation of clonal mast cells with abnormal function. The symptoms and signs o...
Autores principales: | Hamberg Levedahl, Kerstin, Nilsson, Annika, Johansson, Birgitta, Hedström, Mariann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472238/ https://www.ncbi.nlm.nih.gov/pubmed/36069067 http://dx.doi.org/10.1017/S146342362200024X |
Ejemplares similares
-
Mefloquine causes selective mast cell apoptosis in cutaneous mastocytosis lesions by a secretory granule‐mediated pathway
por: Lampinen, Maria, et al.
Publicado: (2022) -
CD203c distinguishes the erythroid and mast cell‐basophil differentiation trajectories among human FcεRI(+) bone marrow progenitors
por: Grootens, Jennine, et al.
Publicado: (2019) -
Multidisciplinary Challenges in Mastocytosis and How to Address with Personalized Medicine Approaches
por: Valent, Peter, et al.
Publicado: (2019) -
Phenotypic and Genotypic Characteristics of Mastocytosis According to the Age of Onset
por: Lanternier, Fanny, et al.
Publicado: (2008) -
Current Concepts on Diagnosis and Treatment of Mastocytosis
por: Magliacane, D., et al.
Publicado: (2014)